Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Semaglutide in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis

NCT04822181 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT04822181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04822181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Semaglutide in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 1, 2021
Completion date
April 25, 2029
Enrollment
1,205 (actual)
Sites
558

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic steatohepatitis